Search details
1.
TGF-ß superfamily co-receptors in cancer.
Dev Dyn
; 251(1): 137-163, 2022 01.
Article
in English
| MEDLINE | ID: mdl-33797167
2.
Cabozantinib and Panitumumab for RAS Wild-Type Metastatic Colorectal Cancer.
Oncologist
; 26(6): 465-e917, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33469991
3.
Endoglin interacts with VEGFR2 to promote angiogenesis.
FASEB J
; 32(6): 2934-2949, 2018 06.
Article
in English
| MEDLINE | ID: mdl-29401587
4.
Heparan sulfate signaling in cancer.
Trends Biochem Sci
; 39(6): 277-88, 2014 Jun.
Article
in English
| MEDLINE | ID: mdl-24755488
5.
Heparin-binding epidermal growth factor-like growth factor promotes neuroblastoma differentiation.
FASEB J
; 31(5): 1903-1915, 2017 05.
Article
in English
| MEDLINE | ID: mdl-28174207
6.
Endoglin Mediates Vascular Maturation by Promoting Vascular Smooth Muscle Cell Migration and Spreading.
Arterioscler Thromb Vasc Biol
; 37(6): 1115-1126, 2017 06.
Article
in English
| MEDLINE | ID: mdl-28450296
7.
TGF-ß-induced stromal CYR61 promotes resistance to gemcitabine in pancreatic ductal adenocarcinoma through downregulation of the nucleoside transporters hENT1 and hCNT3.
Carcinogenesis
; 37(11): 1041-1051, 2016 11 01.
Article
in English
| MEDLINE | ID: mdl-27604902
8.
Endoglin mediates fibronectin/α5ß1 integrin and TGF-ß pathway crosstalk in endothelial cells.
EMBO J
; 31(19): 3885-900, 2012 Oct 03.
Article
in English
| MEDLINE | ID: mdl-22940691
9.
Dichotomous roles of TGF-ß in human cancer.
Biochem Soc Trans
; 44(5): 1441-1454, 2016 10 15.
Article
in English
| MEDLINE | ID: mdl-27911726
10.
Novel bone morphogenetic protein signaling through Smad2 and Smad3 to regulate cancer progression and development.
FASEB J
; 28(3): 1248-67, 2014 Mar.
Article
in English
| MEDLINE | ID: mdl-24308972
11.
Effects of the combination of TRC105 and bevacizumab on endothelial cell biology.
Invest New Drugs
; 32(5): 851-9, 2014 Oct.
Article
in English
| MEDLINE | ID: mdl-24994097
12.
Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer.
Invest New Drugs
; 32(2): 330-9, 2014 Apr.
Article
in English
| MEDLINE | ID: mdl-24173967
13.
The type III TGFß receptor regulates filopodia formation via a Cdc42-mediated IRSp53-N-WASP interaction in epithelial cells.
Biochem J
; 454(1): 79-89, 2013 Aug 15.
Article
in English
| MEDLINE | ID: mdl-23750457
14.
NRP1 interacts with endoglin and VEGFR2 to modulate VEGF signaling and endothelial cell sprouting.
Commun Biol
; 7(1): 112, 2024 01 19.
Article
in English
| MEDLINE | ID: mdl-38242992
15.
A phase II study of capecitabine, oxaliplatin, and bevacizumab in the treatment of metastatic esophagogastric adenocarcinomas.
Oncologist
; 18(3): 271-2, 2013.
Article
in English
| MEDLINE | ID: mdl-23485624
16.
Assessing the utility of molecular diagnostic classification for cancers of unknown primary.
Cancer Med
; 12(19): 19394-19405, 2023 10.
Article
in English
| MEDLINE | ID: mdl-37712677
17.
Gfi-1B controls human erythroid and megakaryocytic differentiation by regulating TGF-beta signaling at the bipotent erythro-megakaryocytic progenitor stage.
Blood
; 115(14): 2784-95, 2010 Apr 08.
Article
in English
| MEDLINE | ID: mdl-20124515
18.
Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs.
Blood
; 116(23): e118-27, 2010 Dec 02.
Article
in English
| MEDLINE | ID: mdl-20733160
19.
The type III TGF-beta receptor regulates epithelial and cancer cell migration through beta-arrestin2-mediated activation of Cdc42.
Proc Natl Acad Sci U S A
; 106(20): 8221-6, 2009 May 19.
Article
in English
| MEDLINE | ID: mdl-19416857
20.
A phase II trial of bevacizumab plus everolimus for patients with refractory metastatic colorectal cancer.
Oncologist
; 16(8): 1131-7, 2011.
Article
in English
| MEDLINE | ID: mdl-21795432